Wellstone Research Update 2020
Jan 25, 2020
Posted by Friends of FSH Research on Nov 5, 2019
Location: Rainier Room
Hyatt Regency Lake Washington
Time: 1 - 4 pm
RSVP
Please join the Seattle Wellstone Center along with Friends of FSH Research in a Research Update on January 25, 2020 prior to the auction. We will discuss recent research advances and the FSHD Clinical Project of the University of Washington NIH-funded Paul D. Wellstone Muscular Dystrophy Cooperative Research Center.
Agenda
| 1:00-1:15 Welcome Jeff Chamberlain, PhD Director, Wellstone Center Professor of Neurology, Medicine, and Biochemistry McCaw Endowed Chair in Muscular Dystrophy University of Washington |
||
| 1:15-2:15 | ||
| Treating FSHD by targeting histone demethylase Danielle C Hamm, PhD Post-doctoral Fellow Wellstone/Friends of FSH Fellow Fred Hutchinson Cancer Research Center |
Epigenetics in FSHD Peter Jones, PhD Associate Professor Mick Hitchcock Endowed Chair of Medical Biochemistry University of Neveda, Reno |
Ribosome footprinting in FSHD Sujatha Jagannathan, PhD Assistant Professor of Biochemistry and Molecular Genetics; University of Colorado |
| 2:15-3:40 | ||
| Using Networks to (Re)solve FSHD Jeff Statland, MD Associate Professor of Neurology Kansas University Medical Center |
Fulcrum Therapeutics: Losmapimod to treat FSHD Michelle Mellion, MD Medical Director Fulcrum Therapeutics |
FSHD Studies at UW Leo H Wang, MD PhD Associate Professor of Neurology University of Washington |
| ~3:40 Round table 2020 Vision: What do you see happening in FSHD in the next five years |
||
The meeting will be held prior to the Annual Auction at the Hyatt (Hyatt Regency Lake Washington at Seattle's Southport), and will concluded with plenty of time to get ready for our Annual Auction at 5pm.
Please sign up via this RSVP for the Wellstone Meeting to help us know if we need a larger room. Thank you!
Connect with us on social media